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neous gastrostomy wound infections due to
resistant organisms
Wound infection following the placement of a percutaneous
endoscopic gastrostomy (PEG) is believed to be a minor
problem.1 However, as many patients requiring PEG are
elderly with co-morbidities, PEG wound infections caused
by an increasing incidence of resistant organisms2,3 may not
be so benign. We report a single tertiary center’s experience
of PEG wound infections where these are due mostly
to resistant organisms, representing a significant clinical
burden.
A retrospective case—control study of 185 patients with
index PEGs inserted at this institution between January 2002
and December 2005 was performed. Dysphagia due to stroke
disease (n = 125, 67.6%) was the most common indication.
The median age was 62 years (range 14—92 years) and 118
(63.7%) patients were male. One hundred and forty-seven
(79.5%) patients were inpatients, and prophylactic antibio-
tics had been administered in 166 (89.7%). A PEG wound
infection (defined as erythema with induration around the
stoma, purulent discharge, and a positive wound culture) was
evident in 49 (26.5%) patients.
Seventy-one organisms were identified in the 49 patients;
20 patients had more than one organism cultured (18 with
two organisms, two with three organisms). Those most com-
monly identified were as follows: Pseudomonas aeruginosa
(n = 27, 38.0%), Klebsiella species (n = 16, 22.5%, of which six
were extended-spectrum b-lactamase producers), methicil-Table 1 Risk factors for percutaneous endoscopic gastrostomy w
Patients with
no infection (N = 136)
Pati
infe
Age >65 years 52 (38.2%) 24 (
Male gender 85 (62.5%) 33 (
Inpatient 105 (77.2%) 42 (
Stroke disease 79 (58.1%) 39 (
Diabetes mellitus 38 (27.9%) 24 (
Pre-infection 21 (15.4%) 11 (
Prophylactic antibiotics 126 (92.6%) 40 (
Blenderized diet 29 (21.3%) 10 (
Albumin <28 g/l 45 (33.1%) 24 (
OR, odds ratio; CI, confidence interval.
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doi:10.1016/j.ijid.2007.09.019lin-sensitive Staphylococcus aureus (n = 10, 14.1%), and
methicillin-resistant Staphylococcus aureus (n = 8, 11.3%).
Clinical parameters in patients with PEG infection
revealed pyrexia in four (8.2%) and leukocytosis in 35
(71.4%). Thirty (61.2%) patients received antibiotics and 20
(40.8%) patients required premature gastrostomy removal.
Six (12.2%) patients developed a non-healing gastrocuta-
neous fistula after PEG removal. Five out of six of these
cases had prolonged naso-enteric tube feeding and the sixth
patient required surgical correction of the fistula. Patients
with PEG infections had a longer mean inpatient stay
(19.1  3.1 days) compared to patients with no PEG compli-
cations (0.3  0.2 days; p < 0.001).
Risk factors for PEG wound infections were analyzed
between cases (i.e., those with PEG infections) and controls
(i.e., those with a PEG with no infection) and the data are
summarized in Table 1. Patients with PEG wound infections
were older ( p = NS), mostly inpatients ( p = NS), had a higher
prevalence of stroke disease ( p = 0.012) and diabetes
( p = 0.013), and had a lower rate of prophylactic antibiotic
administration ( p = NS). Amongst these, we noted that most
of the prophylactic antibiotics administered (i.e., penicillins
8.3%, second generation cephalosporins 50%, and third gen-
eration cephalosporins 41.7%) were not appropriate for the
causative organisms. It is recognized that organisms cultured
from PEG wounds may reflect normal enteric flora and not
necessarily the primary pathogens of wound infections. How-
ever, when examined by antibiotic class, PEG wound infec-
tion rates were noted to be lower in those receiving third
generation cephalosporins (18.8%) compared to patients whoound infections
ents with
ction (N = 49)
p-Value OR 95% CI
49.0%) 0.20 1.53 0.79—2.96
67.3%) 0.81 0.91 0.39—2.08
85.7%) 0.21 1.77 0.72—4.33
79.6%) 0.012 2.74 1.22—6.15
49.0%) 0.013 2.32 1.18—4.56
22.4%) 0.31 1.51 0.67—3.43
81.6%) 0.08 0.51 0.23—1.09
20.4%) 0.22 0.58 0.23—1.41
49.0%) 0.27 1.49 0.73—3.04
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e150 Correspondencereceived either penicillins (37.5%) or second generation
cephalosporins (31.0%; p = NS).
We conclude that resistant organisms causing PEG wound
infections are a significant problem with a major clinical
impact. Our data suggest that standard antibiotic prophylaxis
according to guidelines4 may not be appropriate due to the
increased prevalence of resistant organisms.
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